Anti-inflammatory and immune-regulatory mechanisms prevent contact hypersensitivity to Arnica montana L

Experimental Dermatology

Volumn 17, Issue 10, 2008, Pages 849-857

  Lass, Christian ^a,b   Vocanson, Marc ^c   Wagner, Steffen ^b   Schempp, Christoph M ^a   Nicolas, Jean Francois ^c   Merfort, Irmgard ^b   Martin, Stefan F ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c University Lyon i   (France)

Author keywords

Arnica; Contact dermatitis; Inflammation; NF B; Sesquiterpene lactone

Indexed keywords

11ALPHA,13 DIHYDROHELENALINISOBUTYRATE; 11ALPHA,13 DIHYDROHELENALINMETHACRYLATE; BENZENE DERIVATIVE; CD4 ANTIGEN; CONTACT ALLERGEN; CYTOKINE; HELENALINISOBUTYRATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; SESQUITERPENE LACTONE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARNICA MONTANA; ARTICLE; CELL ACTIVATION; CONCENTRATION RESPONSE; CONTACT ALLERGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DILUTION; DRUG POTENCY; DRUG STRUCTURE; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; IMMUNOCOMPETENCE; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; LYMPHOCYTE DEPLETION; MOUSE; NONHUMAN; SKIN INFLAMMATION; STRUCTURE ANALYSIS; TINCTURE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ARNICA; CD4-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; DERMATITIS, CONTACT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; IRRITANTS; LACTONES; LIGANDS; LIPOPOLYSACCHARIDES; MEDICINE, TRADITIONAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; NF-KAPPA B; PHYTOTHERAPY; RECEPTORS, ANTIGEN, T-CELL; SESQUITERPENES; TOLL-LIKE RECEPTOR 4;

EID: 51949114082     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2008.00717.x     Document Type: Article

References (43)

1. Merfort I. Arnica: New insights on the molecular mode of action of a traditional medicinal plant. Forsch Komplementarmed Klass Naturheilkd Suppl 2003: 1: 45-48.
2. Willuhn G, Leven W. Zur qualitativen und quantitativen Analyse der Sesquiterpenlactone von Arnikablüten DAB 9. Pharm Ztg Wiss 1991: 136: 32-39.
3. Garcia-Pineres A J, Castro C, Mora G et al. Cysteine 38 in p65/NF-kappa B plays a crucial role in DNA binding inhibition by sesquiterpene lactones. J Biol Chem 2001: 276: 39713-39720.
4. Lyss G, Knorre A, Schmidt T J, Pahl H L, Merfort I. The anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF-kappaB by directly targeting p65. J Biol Chem 1998: 273: 33508-33516.
5. Martin S F. T-lymphocyte mediated immune responses to chemical haptens and metal ions - implications for allergic and autoimmune disease. Int Arch Allergy Immunol 2004: 134: 186-198.
6. Martin S F, Merfort I, Thierse H J. Interactions of chemicals and metal ions with proteins and role for immune responses. Mini Rev Med Chem 2006: 6: 247-255.
7. Saint-Mezard P, Berard F, Dubois B, Kaiserlian D, Nicolas J F. The role of CD4+ and CD8+ T cells in contact hypersensitivity and allergic contact dermatitis. Eur J Dermatol 2004: 14: 131-138.
8. + T cell trafficking to inflamed skin. Role for tissue microenvironment and dendritic cells in establishment of T cell homing subsets. J Immunol 2004: 172: 857-863.
9. Dudda J C, Martin S F. Tissue-targeting of T cells by DCs and microenvironments. Trends Immunol 2004: 25: 417-421.
10. Dudda J C, Lembo A, Bachtanian E et al. Dendritic cells govern induction and reprogramming of polarized tissue-selective homing receptor patterns of T cells: Important role for soluble factors and tissue microenvironment. Eur J Immunol 2005: 35: 1056-1065.
11. Schmidt T J. Toxic activities of sesquiterpene lactones: Structural and biochemical aspects. Curr Org Chem 1999: 3: 577-608.
12. Hausen B M. Arnica allergy. Hautarzt 1980: 31: 10-17.
13. Basketter D A, Andersen K E, Liden C et al. Evaluation of the skin sensitizing potency of chemicals by using the existing methods and considerations of relevance for elicitation. Contact Dermatitis 2005: 52: 39-43.
14. Bruynzeel D P, van Ketel W G, Young E, van Joost T, Smeenk G. Contact sensitization by alternative topical medicaments containing plant extracts. The Dutch Contact Dermatoses Group. Contact Dermatitis 1992: 27: 278-279.
15. Reider N, Komericki P, Hausen B M, Fritsch P, Aberer W. The seamy side of natural medicines: Contact sensitization to arnica (Arnica montana L.) and marigold (Calendula officinalis L.). Contact Dermatitis 2001: 45: 269-272.
16. Basketter D A, Smith Pease C K, Patlewicz G Y. Contact allergy: The local lymph node assay for the prediction of hazard and risk. Clin Exp Dermatol 2003: 28: 218-221.
17. Meller S, Lauerma A I, Kopp F M et al. Chemokine responses distinguish chemical-induced allergic from irritant skin inflammation: Memory T cells make the difference. J Allergy Clin Immunol 2007: 119: 1470-1480.
18. Pircher H, Burki K, Lang R, Hengartner H, Zinkernagel R M. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature 1989: 342: 559-561.
19. Cosgrove D, Gray D, Dierich A et al. Mice lacking MHC class II molecules. Cell 1991: 66: 1051-1066.
20. Willuhn G, Röttger P M, Matthiesen U. Helenalin- and 11,13-dihydrohelenalinester from flowers of Arnica montana. Planta Med 1983: 49: 226-231.
21. Vocanson M, Hennino A, Cluzel-Tailhardat M et al. CD8+ T cells are effector cells of contact dermatitis to common skin allergens in mice. J Invest Dermatol 2006: 126: 815-820.
22. Martin S F, Dudda J C, Delattre V et al. Fas-mediated inhibition of CD4+ T cell priming results in dominance of type 1 CD8+ T cells in the immune response to the contact sensitizer trinitrophenyl. J Immunol 2004: 173: 3178-3185.
23. Kyburz D, Aichele P, Speiser D E, Hengartner H, Zinkernagel R M, Pircher H T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides. Eur J Immunol 1993: 23: 1956-1962.
24. + Tc1 cells is associated with the murine immune response to the contact sensitizer trinitrophenyl. Exp Dermatol 2003: 12: 78-85.
25. + T cells are the dominant effector cells in trinitrophenyl-specific contact hypersensitivity. J Invest Dermatol 2000: 115: 260-266.
26. Goebeler M, Roth J, Brocker E B, Sorg C, Schulze-Osthoff K. Activation of nuclear factor-kappa B and gene expression in human endothelial cells by the common haptens nickel and cobalt. J Immunol 1995: 155: 2459-2467.
27. Aiba S, Manome H, Nakagawa S et al. p38 mitogen-activated protein kinase and extracellular signal-regulated kinases play distinct roles in the activation of dendritic cells by two representative haptens, NiCl2 and 2,4-dinitrochlorobenzene. J Invest Dermatol 2003: 120: 390-399.
28. Matura M, Goossens A. Contact allergy to corticosteroids. Allergy 2000: 55: 698-704.
29. Isaksson M, Bruze M. Corticosteroids. Dermatitis 2005: 16: 3-5.
30. Wagner S, Kratz F, Merfort I. In vitro behaviour of sesquiterpene lactones and sesquiterpene lactone-containing plant preparations in human blood, plasma and human serum albumin solutions. Planta Med 2004: 70: 227-233.
31. Wagner S, Suter A, Merfort I. Skin penetration studies of Arnica preparations and of their sesquiterpene lactones. Planta Med 2004: 70: 897-903.
32. Klaas C A, Wagner G, Laufer S et al. Studies on the anti-inflammatory activity of phytopharmaceuticals prepared from Arnica flowers. Planta Med 2002: 68: 385-391.
33. Kos O, Lindenmeyer M T, Tubaro A, Sosa S, Merfort I. New sesquiterpene lactones from Arnica tincture prepared from fresh flowerheads of Arnica montana. Planta Med 2005: 71: 1044-1052.
34. Girolomoni G, Gisondi P, Ottavini C, Cavani A. Immunoregulation of allergic contact dermatitis. J Dermatol 2004: 31: 264-270.
35. Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004: 22: 531-562.
36. Edele F, Esser P R, Lass C et al. Innate and adaptive immune responses in allergic contact dermatitis and autoimmune skin diseases. Inflamm Allergy -Drug Targets 2007: 6: 236-244.
37. Martin SF. Chemical-induced contact hypersensitivity in the mouse model. In: Drug Hypersensitivity, ed. Werner Pichler, MD. Basel: Karger, 2007: 34-46.
38. Baumer W, Krekeler S, DeVries V C, Niedorf F, Tschernig T, Kietzmann M. Non-steroidal and steroidal anti-inflammatory drugs vary in their modulation of dendritic cell function in the elicitation phase of allergic contact dermatitis. Exp Dermatol 2006: 15: 322-329.
39. Luger T A, Brzoska T. Alpha-MSH related peptides: A new class of anti-inflammatory and immunomodulating drugs. Ann Rheum Dis 2007: 66 (Suppl 3): Iii52-iii55.
40. Baumer W, Hoppmann J, Rundfeldt C, Kietzmann M. Highly selective phosphodiesterase 4 inhibitors for the treatment of allergic skin diseases and psoriasis. Inflamm Allergy Drug Targets 2007: 6: 17-26.
41. Ingber A, Cohen Y, Krimsky M, Yedgar S. A novel treatment of contact dermatitis by topical application of phospholipase A2 inhibitor: A double-blind placebo-controlled pilot study. Int J Immunopathol Pharmacol 2007: 20: 191-195.
42. Karsak M, Gaffal E, Date R et al. Attenuation of allergic contact dermatitis through the endocannabinoid system. Science 2007: 316: 1494-1497.
43. Gorbachev A V, Gasparian A V, Gurova K V, Gudkov A V, Fairchild R L. Quinacrine inhibits the epidermal dendritic cell migration initiating T cell-mediated skin inflammation. Eur J Immunol 2007: 37: 2257-2267.